Standardization of a model to study revaccination against Marek's disease under laboratory conditions

Avian Pathology

Volumn 41, Issue 1, 2012, Pages 59-68

  Gimeno, Isabel M ^a   Witter, Richard L ^b   Cortes, Aneg L ^a   Reddy, Sanjay M ^c   Pandiri, Arun R ^a,d  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVES; GALLUS GALLUS;

EID: 84858225037     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079457.2011.635636     Document Type: Article

References (43)

1. Ball, R.F. and Lyman, J. 1977. Revaccination of chicks for Marek's disease at twenty-one days old. Avian Diseases, 21: 440-444.
2. Benda, V. and Holzanek, I. 1975. Effect of large doses of turkey herpes virus on antibody response in chickens. Folia Biologica, 21: 184-188.
3. Calnek, B.W., Schat, K.A., Peckham, M.C. and Fabricant, J. 1983. Research note-Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Diseases, 27: 844-849.
4. Cho, B.R., Balch, R.K. and Hill, R.W. 1976. Marek's disease vaccine breaks: differences in viremia of vaccinated chickens between those with and without Marek's disease. Avian Diseases, 20: 496-503.
5. Churchill, A.E. and Biggs, P.M. 1968. Herpes-type virus isolated in cell culture from tumors of chickens with Marek's disease. II. Studies in vivo. Journal of the National Cancer Institute, 41: 951-956.
6. Cortes, A.L., Montiel, E.R. and Gimeno, I.M. 2009. Validation of Marek's disease diagnosis and monitoring of Marek's disease vaccines from samples collected in FTA cards. Avian Diseases, 53: 510-516.
7. Cortes, A.L., Montiel, E.R., Lemiere, S. & Gimeno, I.M. 2011. Comparison of blood and feather pulp samples for the diagnosis of Marek's disease and for monitoring Marek's disease vaccination by real time PCR. Avian Diseases, 55, 302 - 310.
8. Eleazer, T.H. 1978. Marek's revaccination has no advantage. Poultry Digest, 37: 154
9. Gimeno, I.M., Witter, R.L., Fadly, A.M. and Silva, R.F. 2005. Novel criteria for the diagnosis of Marek's disease virus-induced lymphomas. Avian Pathology, 34: 332-340.
10. Gimeno, I.M., Cortes, A.L. and Silva, R.F. 2008. Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors. Avian Diseases, 52: 203-208.
11. Gimeno, I.M. 2008. Marek's disease vaccines: a solution for today but a worry for tomorrow?. Vaccine, 26(Suppl 3): C31-41.
12. Gimeno, I.M., Cortes, A.L., Montiel, E.R., Lemiere, S. & Pandiri, A.R. 2011a. Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses. Avian Diseases, 55, 263 - 272.
13. Gimeno, I.M., Cortes, A.L., Witter, R.L. & Pandiri, A.R. 2012. Optimization of the protocols for double vaccination against Marek's disease using commercially available vaccines: evaluation of protection, vaccine replication, and activation of T cells. Avian Diseases, in press.
14. Gimeno, I.M. 2004. "Future strategies for controlling Marek's disease". In Marek's disease an evolving problem, Edited by: Davison, F. and Nair, V. 186-198. Oxford: Elsevier.
15. Jones, D., Brunovskis, P., Witter, R.L. and Kung, H.J. 1996. Retroviral insertional activation in a herpesvirus: transcriptional activation of Us genes by an integrated long terminal repeat in a Marek's disease virus clone. Journal of Virology, 70: 2460-2467.
16. Kim, T., Mays, J., Fadly, A. and Silva, R.F. 2011. Artificially inserting a reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of Marek's disease virus (MDV) alters expression of nearby MDV genes. Virus Genes, 42: 369-76.
17. Kuhnlein, U., Spencer, J.L., Chan, M., Praslickova, D., Linher, K., Kulenkamp, A. and Ansah, G. 2006. Relationship between Marek's disease and the time course of viral genome proliferation in feather tips. Avian Diseases, 50: 173-178.
18. Lee, L.F. and Witter, R.L. 1991. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine. Avian Diseases, 35: 452-459.
19. Lee, L.F., Lupiani, B., Silva, R.F., Kung, H.J. and Reddy, S.M. 2008. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV. Vaccine, 26: 1887-1892.
20. Lee, L.F., Kreager, K.S., Arango, J., Paraguassu, A., Beckman, B., Zhang, H., Fadly, A., Lupiani, B. and Reddy, S.M. 2010. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens. Vaccine, 28: 1294-1299.
21. Lupiani, B., Lee, L.F., Cui, X., Gimeno, I., Anderson, A., Morgan, R.W., Silva, R.F., Witter, R.L., Kung, H.J. and Reddy, S.M. 2004. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proceedings of the National Academy of Sciences U S A, 101: 11815-11820.
22. Morrow, C.J. and Fehler, F. 2004. "Marek's disease: a worldwide problem". In Marek's Disease an evolving problem, Edited by: Davison, F. and Nair, V. 49-61. Oxford: Elsevier.
23. Riddell, C., Milne, B.S. and Biggs, P.M. 1978. Herpes virus of turkey vaccine: viraemias in field flocks and in experimental chickens. The Veterinay Record, 102: 123-125.
24. Rispens, B.H., Van Vloten, J., Mastenbroek, N., Maas, H.J.L. and Schat, K.A. 1972a. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Diseases, 16: 108-125.
25. Rispens, B.H., Van Vloten, J., Mastenbroek, N., Maas, H.J.L. and Hendrick, J.L. 1972b. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Diseases, 16: 126-138.
26. Schat, K.A. and Calnek, B.W. 1978. Characterization of an apparently nononcogenic Marek's disease virus. Journal of the National Cancer Institute, 60: 1075-1082.
27. Schat, K.A. and Nair, V.K. 2008. "Marek's disease". In Diseases of Poultry, Edited by: Saif, Y.M., Fadly, A.M., Glisson, J.R., McDougald, L.R., Nolan, L.K. and Swayne, D.E. 449-514. Ames, Iowa: Blackwell Publishing Professionals.
28. Sevoian, M., Chamberlain, D.M. and Counter, F.T. 1962. Avian lymphomatosis. I. Experimental reproduction of the neural and visceral forms. Veterinay Medicine, 57: 500-501.
29. Sharma, J.M. and Burmester, B.R. 1982. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Diseases, 26: 134-149.
30. Sharma, J.M., Lee, L.F. and Wakenell, P.S. 1984. Comparative viral, immunologic and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch. The American Journal of Veterinary Research, 45: 1619-1623.
31. Spencer, J.L., Grunder, A.A., Robertson, A. and Speckmann, G.W. 1972. Attenuated Marek's disease herpesvirus: protection conferred on strains of chickens varying in genetic resistance. Avian Diseases, 16: 94-107.
32. Witter, R.L., Sharma, J.M. and Fadly, A.M. 1980. Pathogenicity of variant Marek's disease virus isolants in vaccinated and unvaccinated chickens. Avian Diseases, 24: 210-232.
33. Witter, R.L., Nazerian, K., Purchase, H.G. and Burgoyne, G.H. 1970. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. The American Journal of Veterinary Research, 31: 525-538.
34. Witter, R.L. and Lee, L.F. 1984. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathology, 13: 75-92.
35. Witter, R.L., Lee, L.F. and Fadly, A.M. 1995. Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus. Avian Diseases, 39: 269-284.
36. Witter, R.L. 1997. Increased virulence of Marek's disease virus field isolates. Avian Diseases., 41: 149-163.
37. Witter, R.L., Li, D., Jones, D., Lee, L.F. and Kung, H.J. 1997. Retroviral insertional mutagenesis of a herpesvirus: a Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication. Avian Diseases, 41: 407-421.
38. Witter, R.L. 2002. Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses. Avian Diseases, 46: 925-937.
39. Witter, R.L. and Kreager, K.S. 2004. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease. Avian Diseases, 48: 768-782.
40. th Congress & Exhibition of the World Veterinary Poultry Association Beijing. pp. 78 - 90.
41. Wu, C., Gan, J., Jin, Q., Chen, C., Liang, P., Wu, Y., Liu, X., Ma, L. and Davison, F. 2009. Revaccination with Marek's disease vaccines induces productive infection and superior immunity. Clinical and Vaccine Immunology, 16: 184-193.
42. Zander, D.V., Hill, R.W., Raymond, R.G., Balch, R.K., Mitchell, R.W. and Dunsing, J.W. 1972. The use of blood from selected chickens as an immunizing agent for Marek's disease. Avian Diseases, 16: 163-178.
43. Zanella, A., Valantines, J., Granelli, G. and Castell, G. 1975. Influence of strain of chickens on the immune response to vaccination against Marek's disease. Avian Pathology, 4: 247-253.